Dr.Gopal S Pillai [P09299] – Kochi,
his instruction course will be a one stop knowledge store for the management of almost all the medical retina conditions treated with intravitreal injections. Intravitreal injections have now become one of the most common therapeutic procedures done by an ophthalmologist. With expanding indications and retreatments, every comprehensive ophthalmologist is compelled to start doing intravitreal injections. The comprehensive ophthalmologists should know the correct indications,contraindications,follow up,retreatment criteria and make them fully competent in giving injections. A video on the correct technique of injection,indications and contraindications,packing and safe use of avastin,strategies of re-treatment and prediction of prognosis in AMD,DME and RVO and complications of anti VEGF will be included. It will also compare the different injections presently available for use. This IC will finish with 3 challenging case discussions and will benefit all comprehensive ophthalmologists.
| 1 | Diabetic Macular Edema – What has changed in the last few years (9 mins) | Dr. Gopal S Pillai | watch video |
| 2 | Wet AMD- How to optimise results with least number of injections in the long term (9 mins) | Dr.Dinesh Talwar | watch video |
| 3 | Retinal vein occlusions- When to start? How to proceed? When to switch? (9 mins) | Dr.Mahesh G | watch video |
| 4 | Intravitreal steroids- What is the current status? (9 mins) | Dr.Anand Rajendran | watch video |
| 5 | Managing the avastin multidose vial- What is safe? (9 mins) | Dr.Thomas Cherian | watch video |
| 6 | Video based lecture- What is the correct technique of injection (9 mins) | Dr. Prakash | watch video |
| 7 | Biosimilar versus Innovator- Where does the world stand now (9 mins) | Dr.Shrinivas M Joshi | watch video |
| 8 | Case based discussion on management dilemmas (12 mins) | Dr.Gopal S Pillai | |
| 9 | Keynote Address by : Prevention of Endophthalmitis afterIntravitreal Injections ( 10 mins. ) | Dr.Kamal Kishore | watch video |
| Panel Discussion : (0 mins.) |


Leave a Comment